TerrAscend TSNDF
OTC TSNDF
$0.59 -0.02 (-3.28%)
At close: Aug 20, 2026 · 4:00 PM EDT

TerrAscend (TSNDF) Liabilities from Discontinued Operations (2021 - 2026)

TerrAscend (TSNDF) posted quarterly Liabilities from Discontinued Operations of 6881000.0 for Q1 2026, down 45.46% quarter-over-quarter from 12616000.0 in Q4 2025.

TerrAscend (TSNDF) Liabilities from Discontinued Operations (2021 - 2026) Analysis & Trends

TerrAscend (TSNDF) has reported Liabilities from Discontinued Operations for 6 consecutive years, with 6881000.0 the latest figure, recorded in Q1 2026.

  • In Q1 2026, Liabilities from Discontinued Operations changed N/A year-over-year to 6881000.0; the TTM figure through Mar 2026 stood at 6881000.0 (changed N/A YoY), while the FY2025 annual figure was 12616000.0, down 48.08% from the prior year.
  • Liabilities from Discontinued Operations declined to 6881000.0 in Q1 2026 per TSNDF's latest filing, from 12616000.0 in the prior quarter.
  • Across five years, Liabilities from Discontinued Operations topped out at 24298000.0 in Q4 2024 and bottomed at 1124000.0 in Q3 2023.
  • Historically, Liabilities from Discontinued Operations has averaged 11312333.33 across 5 years, with a median of 9111000.0 in 2022.
  • Annual changes were most pronounced in 2022 — Liabilities from Discontinued Operations climbed 12.87% — and 2025, when it slumped 48.08%.
  • TerrAscend's Liabilities from Discontinued Operations stood at 9111000.0 in 2022, then tumbled by 87.66% to 1124000.0 in 2023, then surged by 2061.74% to 24298000.0 in 2024, then sank by 48.08% to 12616000.0 in 2025, then plunged by 45.46% to 6881000.0 in 2026.
  • Business Quant data shows TSNDF's Liabilities from Discontinued Operations at 6881000.0 in Q1 2026, 12616000.0 in Q4 2025, and 14856000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 44.51 Bn 43.55 Bn -
2 Teva Pharmaceutical Industries 43.52 Bn 39.86 Bn 2.15 Bn
3 Zoetis 32.43 Bn 30.75 Bn 1.05 Bn
4 Takeda Pharmaceutical 28.63 Bn 22.83 Bn 5.10 Bn
5 United Therapeutics 21.87 Bn 19.21 Bn 683.80 Mn
6 Viatris 18.98 Bn 18.09 Bn 1.46 Bn
7 Neurocrine Biosciences 15.43 Bn 15.04 Bn 935.80 Mn
8 Elanco Animal Health 12.02 Bn 11.49 Bn 798.00 Mn
9 Dr Reddys Laboratories 10.14 Bn 9.98 Bn -
10 TerrAscend 197.99 Mn 155.88 Mn 36.25 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 6.88 Mn
Mar 31, 2026 6.88 Mn
Dec 31, 2025 12.62 Mn
Dec 31, 2025 12.62 Mn
Sep 30, 2025 14.86 Mn
Sep 30, 2025 14.86 Mn
Jun 30, 2025 23.99 Mn
Jun 30, 2025 23.99 Mn
Dec 31, 2024 24.30 Mn
Dec 31, 2024 24.30 Mn
Sep 30, 2023 1.12 Mn
Sep 30, 2023 1.12 Mn
Jun 30, 2023 1.47 Mn
Jun 30, 2023 1.47 Mn
Mar 31, 2023 7.47 Mn
Mar 31, 2023 7.47 Mn
Dec 31, 2022 9.11 Mn
Dec 31, 2022 9.11 Mn
Dec 31, 2021 8.07 Mn
Dec 31, 2021 8.07 Mn